The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Open accessAbstract
Exhausted CD8+ T (T ex) cells in chronic infections and cancer have limited effector function, high co-expression of inhibitory receptors and extensive transcriptional changes compared with effector (T eff) or memory (T mem) CD8+ T cells. T ex cells are important clinical targets of checkpoint blockade and other immunotherapies. Epigenetically, T ex cells are a distinct immune subset, with a unique chromatin landscape compared with T eff and T mem cells. However, the mechanisms that govern the transcriptional and epigenetic development of T ex cells remain unknown. Here we identify the HMG-box transcription factor TOX as a central regulator of T ex cells in mice. TOX is largely dispensable for the formation of T eff and T mem cells, but it is critical for exhaustion: in the absence of TOX, T ex cells do not form. TOX is induced by calcineurin and NFAT2, and operates in a feed-forward loop in which it becomes calcineurin-independent and sustained in T ex cells. Robust expression of TOX therefore results in commitment to T ex cells by translating persistent stimulation into a distinct T ex cell transcriptional and epigenetic developmental program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which transcriptionally and epigenetically programs CD8+ T cell exhaustion [52].”
From Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC (2025) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment‐induced declines in PD‐1+ CD8 T cells are consistent with the possibility that thymus regeneration treatment epigenetically reprograms “exhausted” CD8 T cells (T EX), a recently characterized distinct PD‐1+ CD8 population (Khan et al., 2019).”
From Reversal of epigenetic aging and immunosenescent trends in humans. (2019) · cites this paper as Khan et al., 2019
In the citing paper
“The excessive antigen density and kinetics of antigen exposure in solid tumors can drive exhaustion or dysfunction of T cells (Khan et al., 2019; Wherry, 2011).”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Khan et al., 2019
In the citing paper
“Furthermore, bulk RNA-seq analysis of isolated cells (ND naïve, HFHC Tem, HFHC Trm, and RES Trm) revealed that both Trm subsets from HFHC mice and RES mice expressed core signature genes of Trm21–24 with exceptions including Itgae (CD103) and Eomes (Fig. 4d).”
From CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells (2021) · cites this paper as [24]
In the citing paper
“CD8 T cells are typically regarded as a uniform population with cytotoxic function; however, recent studies have highlighted the diversity of the CD8 T-cell population (5)(6)(7)(8)(9).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Self-citationMaster Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Cited by
Sorted by citations
Items 501–600 of 1,001
Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
Dai, Z., Sezin, T., Chang, Y., Lee, E. Y., Wang, E. H. C., & Christiano, A. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955038 · Cited by 35
Künzli, M., Reuther, P., Pinschewer, D. D., & King, C. G. (2021) · eLife · doi:10.7554/elife.61869 · Cited by 35
Gálvez‐Cancino, F., Navarrete, M., Beattie, G., Puccio, S., Conde, E., Foster, K. A., Morris, Y., Sahwangarrom, T., Karagianni, D., Liu, J., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.021 · Cited by 37
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer
Kannan, K., Srinivasan, A., Kannan, A., & Ali, N. (2025) · Cancers · doi:10.3390/cancers17172938 · Cited by 44
Delyon, J., Zuber, J., Dorent, R., Poujol‐Robert, A., Péraldi, M., Anglicheau, D., & Lebbé, C. (2020) · Transplantation · doi:10.1097/tp.0000000000003292 · Cited by 34
Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling
Pagé, N., Lemeille, S., Vincenti, I., Klimek, B., Mariotte, A., Wagner, I., Liberto, G. D., Kaye, J., & Merkler, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21109-3 · Cited by 36
Self-citationBrauneck, F., Haag, F., Woost, R., Wildner, N. H., Tolosa, E., Rissiek, A., Vohwinkel, G., Wellbrock, J., Bokemeyer, C., Wiesch, J. S. Z., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1930391 · Cited by 34
Active surveillance characterizes human intratumoral T cell exhaustion
You, R., Artichoker, J., Fries, A. C., Edwards, A. W., Combes, A. J., Reeder, G. C., Samad, B., & Krummel, M. F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144353 · Cited by 35
Tomiyama, T., Itoh, S., Iseda, N., Toshida, K., Morinaga, A., Yugawa, K., Kosai‐Fujimoto, Y., Tomino, T., Kurihara, T., Nagao, Y., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13213 · Cited by 33
Hickman, T. L., Choi, E., Whiteman, K. R., Muralidharan, S., Pai, T., Johnson, T., Parikh, A. B., Friedman, T., Gilbert, M., Shen, B., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266980 · Cited by 36
Methionine cycle-dependent regulation of T cells in cancer immunity
Zhao, T., & Lum, J. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.969563 · Cited by 34
Lo, W., Kuhlmann, M., Rizzuto, G. A., Ekiz, H. A., Kolawole, E. M., Revelo, M. P., Andargachew, R., Li, Z., Tsai, Y.-L., Marson, A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01444-x · Cited by 31
Kang, S., Mansurov, A., Kurtanich, T. R., Chun, H. R., Slezak, A. J., Volpatti, L. R., Chang, K., Wang, T., Alpar, A. T., Refvik, K. C., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh9879 · Cited by 34
Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells
Hu, D., Yang, R., Wang, G., Li, H., Fan, X., & Liang, G. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s445101 · Cited by 34
Hao, J., Li, R., Zhao, X., Liu, X., Chen, X., Xie, T., Li, X., Yao, C., Sun, Q., Wei, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114301 · Cited by 35
Self-citationStrongin, Z., Marchand, L. R., Deléage, C., Pampena, M. B., Cardenas, M. A., Beusch, C. M., Hoang, T. N., Urban, E., Gourvès, M., Nguyen, K., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01875-0 · Cited by 37
Gonzalez-Rellan, M. J., Riobello, C., Fang, S., da Silva, E. M., Koehler, J. A., Shang, R., Hammoud, R., Cao, X., Varela‐Rey, M., & Drucker, D. J. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.03.011 · Cited by 39
Reversal of T Cell Exhaustion in Chronic HCV Infection
Osuch, S., Metzner, K. J., & Cortés, K. C. (2020) · Viruses · doi:10.3390/v12080799 · Cited by 34
Tucker, C., Mitchell, J. S., Martinov, T., Burbach, B. J., Beura, L. K., Wilson, J. C., Dwyer, A. J., Singh, L. M., Mescher, M. F., & Fife, B. T. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000007 · Cited by 34
Lewis, E. L., Xu, R., Beltra, J., Ngiow, S. F., Cohen, J. B., Telange, R., Crane, A., Sawinski, D. L., Wherry, E. J., & Porrett, P. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201599 · Cited by 32
Self-citationNguyen, R., Zhang, X., Sun, M., Abbas, S., Seibert, C., Kelly, M. C., Shern, J. F., & Thiele, C. J. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0717 · Cited by 34
TOX regulates T lymphocytes differentiation and its function in tumor
Niu, H., & Wang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.990419 · Cited by 32
Biomechanics of T Cell Dysfunctions in Chronic Diseases
Gunasinghe, S. D., Peres, N. G., Goyette, J., & Gaus, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.600829 · Cited by 33
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury
Hackstein, C.-P., Spitzer, J., Symeonidis, K., Horvatic, H., Bedke, T., Steglich, B., Klein, S., Assmus, L. M., Odainic, A., Szlapa, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.026 · Cited by 33
Systems analysis of innate and adaptive immunity in Long COVID
Peluso, M. J., Abdel‐Mohsen, M., Henrich, T. J., & Roan, N. R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101873 · Cited by 35
Oswald, B. M., DeCamp, L. M., Longo, J., Dahabieh, M. S., Bunda, N., Johnson, B. K., Watson, M. J., Ma, S., Preston, S. E. J., Sheldon, R. D., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01415-6 · Cited by 35
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Zhong, C. F., Li, Y., Yang, J., Jin, S., Chen, G., Li, D., Fan, X., & Lin, H. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.589680 · Cited by 32
γδ T cell exhaustion: Opportunities for intervention
Chen, D., Guo, Y., Jiang, J., Wu, P., Zhang, T., Wei, Q., Huang, J., & Wu, D. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0722-777r · Cited by 31
Riegel, D., Romero-Fernández, E., Simon, M., Adenugba, A., Singer, K., Mayr, R., Weber, F., Kleemann, M., Imbusch, C. D., Kreutz, M. P., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.029 · Cited by 35
Onyshchenko, K., Luo, R., Guffart, E., Gaedicke, S., Grosu, A., Firat, E., & Niedermann, G. (2023) · Nature Communications · doi:10.1038/s41467-023-37825-x · Cited by 31
Kharel, A., Shen, J., Brown, R. J., Chen, Y., Nguyen, C. P., Alson, D., Bluemn, T., Fan, J., Gai, K., Zhang, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112649 · Cited by 32
Collier, J. L., Pauken, K. E., Lee, C. A. A., Patterson, D. G., Markson, S. C., Conway, T. S., Fung, M. E., France, J. A., Mucciarone, K., Lian, C. G., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221920 · Cited by 33
Cytokine signaling in chimeric antigen receptor T-cell therapy
Kagoya, Y. (2023) · International Immunology · doi:10.1093/intimm/dxad033 · Cited by 31
Recent advances in understanding T cell activation and exhaustion during HBV infection
Wang, L., Zeng, X.-Q., Wang, Z., Fang, L.-C., & Liu, J. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.10.007 · Cited by 30
The role of Ca2+-signaling in the regulation of epigenetic mechanisms
Hernández‐Oliveras, A., & Zarain‐Herzberg, Á. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102836 · Cited by 32
Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy
Xiong, D., Yu, H., & Sun, Z. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.022 · Cited by 31
Hou, Y., Žák, J., Shi, Y., Pratumchai, I., Dinner, B., Wang, W., Qin, K., Weber, E. W., Teijaro, J. R., & Wu, P. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0089 · Cited by 33
Tsui, C., Heyden, L., Wen, L., de Graça, C. G., Potemkin, N., Frolov, A., Rawlinson, D., Qin, L., Wimmer, V. C., Hadian-Jazi, M., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02276-7 · Cited by 37
Epigenetic regulation of T cell exhaustion in cancer
Kang, T. G., Johnson, J. T., Zebley, C. C., & Youngblood, B. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00883-y · Cited by 36
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
Tang, X. X., Shimada, H., & Ikegaki, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650427 · Cited by 33
Ring, S. S., Cupovic, J., Onder, L., Lütge, M., Perez‐Shibayama, C., Gil‐Cruz, C., Scandella, E., Martin, A. D., Mörbe, U., Hartmann, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25057-w · Cited by 31
LaPorte, K. M., Hernandez, R., Savio, A. S., & Malek, T. R. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006611 · Cited by 30
Collins, S. M., Alexander, K. A., Lundh, S. M., Dimitri, A. J., Zhang, Z., Good, C. R., Fraietta, J. A., & Berger, S. L. (2023) · Science Advances · doi:10.1126/sciadv.adh2605 · Cited by 33
Self-citationAge-Related Alterations in Peripheral Immune Landscape with Magnified Impact on Post-Stroke Brain
Lü, J., Li, H., Zhang, G., Yang, F., Zhang, X., Ping, A., Xu, Z., Gu, Y., Wang, R., Ying, D., et al. (2023) · Research · doi:10.34133/research.0287 · Cited by 32
The effector program of human CD8 T cells supports tissue remodeling
Delacher, M., Schmidleithner, L., Simon, M., Stüve, P., Sanderink, L., Hotz‐Wagenblatt, A., Wuttke, M., Schambeck, K., Ruhland, B., Hofmann, V., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230488 · Cited by 30
Blise, K. E., Sivagnanam, S., Betts, C. B., Betre, K., Kirchberger, N. C., Tate, B. J., Furth, E. E., Costa, A. D., Nowak, J. A., Wolpin, B. M., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0873 · Cited by 31
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1
Mok, S., Liu, H., Çobanoğlu, D. A., Anang, N.-A. A. S., Mancuso, J. J., Wherry, E. J., & Allison, J. P. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2418985122 · Cited by 30
Self-citationEnabling tumor-specific drug delivery by targeting the Warburg effect of cancer
Zhang, J., Pan, T., Lee, J., Goldberg, S., King, S. A., Tang, E., Hu, Y., Chen, L., Hoover, A., Zhu, L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101920 · Cited by 33
CCR8 + decidual regulatory T cells maintain maternal-fetal immune tolerance during early pregnancy
Li, Z., Si, P., Meng, T., Zhao, X., Zhu, C., Zhang, D., Meng, S., Li, N., Liu, R., Ni, T., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado2463 · Cited by 35
Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy
Zou, D., Li, X. C., & Chen, W. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01321-7 · Cited by 30
Chen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 37
Naeem, M., Hazafa, A., Bano, N., Ali, R., Farooq, M., Razak, S. I. A., Lee, T. Y., & Devaraj, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121409 · Cited by 32
CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes
Koyama‐Nasu, R., Kimura, M. Y., Kiuchi, M., Aoki, A., Wang, Y., Mita, Y., Hasegawa, I., Endo, Y., Onodera, A., Hirahara, K., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0406 · Cited by 28
Wang, W., Guo, M.-N., Li, N., Pang, D.-Q., & Wu, J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i6.1124 · Cited by 29
Self-citationAljobaily, N. A., Allard, D., Perkins, B., Raugh, A., Galland, T., Jing, Y., Stephens, W. Z., Bettini, M. L., Hale, J. S., & Bettini, M. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.016 · Cited by 30
The epigenetic landscape of fate decisions in T cells
Jay, A., Pondevida, C. M., & Vahedi, G. (2025) · Nature Immunology · doi:10.1038/s41590-025-02113-x · Cited by 32
Guo, X., Ma, S., Wang, J., Fu, Y., & Ma, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1709852 · Cited by 29
Epigenetics of T cell fate decision
Pace, L., & Amigorena, S. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.002 · Cited by 30
Watanabe, T., Firat, E., Scholber, J., Gaedicke, S., Heinrich, C., Luo, R., Ehrat, N., Multhoff, G., Schmitt-Graeff, A. H., Grosu, A., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02587-8 · Cited by 30
Tissue environment, not ontogeny, defines murine intestinal intraepithelial T lymphocytes
Brenes, A. J., Vandereyken, M., James, O. J., Watt, H. J., Hukelmann, J. L., Spinelli, L., Dikovskaya, D., Lamond, A. I., & Swamy, M. (2021) · eLife · doi:10.7554/elife.70055 · Cited by 28
Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
Martin, G. E., Sen, D. R., Pace, M. J., Robinson, N., Meyerowitz, J., Adland, E., Thornhill, J. P., Jones, M., Ogbe, A., Parolini, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.647688 · Cited by 30
Dudek, M., Lohr, K., Donakonda, S., Baumann, T., Luedemann, M., Hegenbarth, S. I., Dübbel, L., Eberhagen, C., Michailidou, S., Yassin, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110389 · Cited by 29
Zhang, S., Yu, F., Che, A., Tan, B., Huang, C., Chen, Y., Liu, X., Huang, Q., Zhang, W., Ma, C., et al. (2022) · Advanced Science · doi:10.1002/advs.202104132 · Cited by 28
Ding, L., Yu, Q., Yang, S., Yang, W., Liu, T., Xian, J., Tian, T., Li, T., Chen, W., Wang, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831101 · Cited by 30
Beider, K., Itzhaki, O., Schachter, J., Grushchenko-Polaq, A. H., Voevoda-Dimenshtein, V., Rosenberg, E., Ostrovsky, O., Devillers, O., Frommer, R. S., Zeltzer, L., et al. (2022) · Cells · doi:10.3390/cells11071140 · Cited by 30
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Attianese, G. M. P. G., Ash, S., & Irving, M. B. (2023) · Immunological Reviews · doi:10.1111/imr.13252 · Cited by 29
Charting the Roadmap of T Cell Exhaustion
Chu, T., & Zehn, D. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.019 · Cited by 30
Determinants of anti-PD1 response and resistance in clear cell renal cell carcinomaPreprint
Au, L., Hatipoglu, E., de Massy, M. R., Litchfield, K., Rowan, A., Thompson, R. H., Schnidrig, D., Byrne, F., Beattie, G., Horswell, S. D., et al. (2021) · medRxiv · doi:10.1101/2021.03.19.21253661 · Cited by 29
Kang, K., Wu, Y., Chang, H., Wang, L., Wang, Z., & Zhao, A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106836 · Cited by 30
Byl, W. V. D., Nüssing, S., Peters, T. J., Ahn, A., Li, H., Ledergor, G., David, E., Koh, A. S., Wagle, M. V., Deguit, C. D. T., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.026 · Cited by 32
Roussot, N., Kaderbhaï, C., & Ghiringhelli, F. (2025) · Cancers · doi:10.3390/cancers17050906 · Cited by 29
Transcriptional and epigenetic regulation of memory NK cell responses
Beaulieu, A. M. (2021) · Immunological Reviews · doi:10.1111/imr.12947 · Cited by 29
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
Yang, M., Huang, Q., Li, C., Jiang, Z., Sun, J. P., Wang, Z., Liang, R., Li, D., Li, B., & Zhao, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.647540 · Cited by 29
Dornieden, T., Sattler, A., Reguant, A. P., Ruhm, A. H., Thiel, L. G., Bergmann, Y., Thole, L. M. L., Köhler, R., Kühl, A. A., Hauser, A. E., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020101528 · Cited by 32
Raju, S., Xia, Y., Dániel, B., Yost, K. E., Bradshaw, E., Tonc, E., Verbaro, D., Kometani, K., Yokoyama, W. M., Kurosaki, T., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001348 · Cited by 31
Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
Ronen, D., Bsoul, A., Lotem, M., Abedat, S., Yarkoni, M., Amir, O., & Asleh, R. (2022) · Vaccines · doi:10.3390/vaccines10040540 · Cited by 29
Chaudhary, O., Trotta, D., Wang, K., Wang, X., Chu, X., Bradley, C., Okulicz, J. F., Maves, R. C., Kronmann, K., Schofield, C. M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004564 · Cited by 29
Zander, R., Khatun, A., Kasmani, M. Y., Chen, Y., & Cui, W. (2022) · eLife · doi:10.7554/elife.80079 · Cited by 28
Metabolic Control of Memory T-Cell Generation and StemnessPreprint
Raynor, J. L., Chapman, N. M., & Chi, H. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037770 · Cited by 28
Witt, M., Oliveira‐Ferrer, L., Koch‐Nolte, F., Menzel, S., Hell, L., Sturmheit, T., Seubert, E., Weimer, P., Ding, Y., Qi, M., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2346359 · Cited by 29
Hepatitis E virus: from innate sensing to adaptive immune responses
Brüggemann, Y., Klöhn, M., Wedemeyer, H. H., & Steinmann, E. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00950-z · Cited by 26
Wu, M., Wu, Y., Jin, Y., Mao, X., Zeng, S., Yu, H., Zhang, J., Jin, Y., Wu, Y., Xu, T., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00644 · Cited by 27
Lawton, M. L., Inge, M. M., Blum, B. C., Smith-Mahoney, E. L., Bolzan, D., Lin, W., McConney, C., Porter, J., Moore, J., Youssef, A., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002943 · Cited by 25
Clark, M. L., Simeonov, K. P., Mowel, W. K., Michieletto, M. F., Joannas, L. D., Wright, J. M., Erickson, I., Johnson, L. R., Krishnan, R., de la Fuente‐Núñez, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.006 · Cited by 29
Trib1 regulates T cell differentiation during chronic infection by restraining the effector program
Rome, K., Stein, S. J., Kurachi, M., Petrovic, J., Schwartz, G. W., Mack, E. A., Uljon, S., Wu, W. W., DeHart, A. G., McClory, S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190888 · Cited by 26
Self-citationYu, X., Zhang, L., Chaudhry, A., Rapaport, A. S., & Ouyang, W. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0320-234r · Cited by 25
Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
Nagai, N., Kudo, Y., Aki, D., Nakagawa, H., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052238 · Cited by 30
Kanda, Y., Okazaki, T., & Katakai, T. (2021) · Cancers · doi:10.3390/cancers13184616 · Cited by 30
Ou, K., Hamo, D., Schulze, A. S., Roemhild, A., Kaiser, D., Gasparoni, G., Salhab, A., Zarrinrad, G., Amini, L., Schlickeiser, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751590 · Cited by 25
Stelekati, E., Cai, Z., Manne, S., Chen, Z., Beltra, J., Buchness, L. A., Leng, X., Ristin, S., Nzingha, K., Ekshyyan, V., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106083119 · Cited by 24
Self-citationReprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
Perdomo-Celis, F., Passaes, C., Monceaux, V., Volant, S., Boufassa, F., de Truchis, P., Marcou, M., Bourdic, K., Weiss, L., Jung, C., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 27
Exhaustion of CD39-Expressing CD8+ T Cells in Crohn’s Disease Is Linked to Clinical Outcome
Globig, A.-M., Mayer, L., Heeg, M., Andrieux, G., Ku, M., Otto-Mora, P., Hipp, A. V., Zoldan, K., Pattekar, A., Rana, N., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.045 · Cited by 30
Self-citationEmpowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
Alvanou, M., Lysandrou, M., Christofi, P., Psatha, N., Spyridonidis, A., Παπαδοπούλου, Α., & Yannaki, E. (2023) · Cancers · doi:10.3390/cancers15071935 · Cited by 28
Regulatory Mechanisms and Reversal of CD8+T Cell Exhaustion: A Literature Review
Zhu, W., Li, Y., Han, M., & Jiang, J. (2023) · Biology · doi:10.3390/biology12040541 · Cited by 28
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8 + T Cell Immunity against Tumor
Yu, A., Fu, J., Yin, Z. Q., Yan, H. M., Xiao, X., Zou, D., Zhang, X., Zu, X., Li, X. C., & Chen, W. (2023) · Research · doi:10.34133/research.0271 · Cited by 28
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion
Munter, S. D., Buhl, J. L., Cock, L. D., Parys, A. V., Daneels, W., Pascal, E., Deseins, L., Ingels, J., Goetgeluk, G., Jansen, H., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0677 · Cited by 28
Yue, B., Gao, Y., Hu, Y., Zhan, M., Wu, Y., & Lu, L. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1731 · Cited by 26
Stem-like CD8+ T cells in cancer
Steiner, C., Denlinger, N., Huang, X., & Yang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1426418 · Cited by 28
Role of kynurenine in promoting the generation of exhausted CD8+ T cells in colorectal cancer.
Wu, D., & Zhu, Y. (2021) · PubMed · Cited by 26
Epigenetic Regulation of Cancer Immune Cells
Patino, D. M. A., Radhakrishnan, V., Suvilesh, K. N., Manjunath, Y., Li, G., Kimchi, E. T., Staveley-O’Carroll, K. F., Warren, W. C., Kaifi, J. T., & Mitchem, J. B. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.022 · Cited by 26
Metadata
- Authors
- Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., Attanasio, J., Yan, P., George, S. M., Bengsch, B., Staupe, R. P., Donahue, G., Xu, W., Amaravadi, R. K., Xu, X., Karakousis, G. C., Mitchell, T. C., Schuchter, L. M., Kaye, J., Berger, S. L., & Wherry, E. J.
- Affiliations
- Arsenal Biosciences (United States) (US)
- University of Pennsylvania (US)
- University of Freiburg (DE)
- Abramson Cancer Center (US)
- Cedars-Sinai Medical Center (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Wherry, E. John
- ORCID
- Khan, Omar
- Giles, Josephine R.
- McDonald, Sierra
- Manne, Sasikanth
- Ngiow, Shin Foong
- Patel, Kunal P.
- Werner, Michael T.
- Huang, Alexander C.
- Alexander, Katherine A.
- Wu, Jennifer E.
- Attanasio, John
- Yan, Patrick
- Bengsch, Bertram
- Staupe, Ryan P.
- Donahue, Greg
- Xu, Wei
- Amaravadi, Ravi K.
- Xu, Xiaowei
- Karakousis, Giorgos C.
- Mitchell, Tara C.
- Schuchter, Lynn M.
- Kaye, Jonathan
- Berger, Shelley L.
- Wherry, E. John
- Venue
- Nature
- Published
- 2019-06-17
- Volume
- 571
- Issue
- 7764
- Pages
- 211-218
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6713202
- OpenAlex
- W2952815301
- Cited by
- 1,646
- References
- 63
- Citations by year
- 2026: 258 · 2025: 249 · 2024: 234 · 2023: 252 · 2022: 211 · 2021: 235 · 2020: 161 · 2019: 43
- FWCI
- 64.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA078831, F32CA221010, P30CA010815, P01CA210944)
- National Institute of Allergy and Infectious Diseases (R01AI115712, R01AI054977, R01AI105343, F30AI129263, U19AI117950, U19AI082630, P01AI108545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- TOX transcription factor, CD8+ T cell exhaustion, chromatin landscape, epigenetic regulation, calcineurin, NFATc1, feed-forward loop, inhibitory receptors, chronic infection, cancer immunotherapy, checkpoint blockade, transcriptional programs
- MeSH terms
- Animals, Epistasis, Genetic, Female, Gene Expression Regulation, Genotype, Immunologic Memory, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Transcription, Genetic, Homeodomain Proteins, CD8-Positive T-Lymphocytes, Tumor Escape, Calcineurin, Calcium Signaling, Feedback, Physiological, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review